Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Orelabrutinib |
| Trade Name | |
| Synonyms | ICP-022|ICP022|ICP 022 |
| Drug Descriptions |
Orelabrutinib (ICP-022) inhibits BTK, potentially resulting in decreased growth of BTK-expressing tumor cells (NCI Drug Dictionary). |
| DrugClasses | BTK inhibitor 38 |
| CAS Registry Number | 1655504-04-3 |
| NCIT ID | C156173 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Orelabrutinib | Orelabrutinib | 0 | 1 |